Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Le Chesnay-Rocquencourt, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
FranceStudy on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)
FranceStudy on the Safety and Effectiveness of Vepdegestrant and Samuraciclib for Adults with ER+ Advanced or Metastatic Breast Cancer
FranceStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
FranceLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
FranceStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
FranceStudy of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
FranceStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
FranceStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
FranceStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
FranceLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
FranceStudy on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myocardial infarction pain management and innovative treatments for severe asthma. Research includes evaluation of novel pain-relief methods and assessment of treatment discontinuation strategies.
Studies also examine beta-blocker discontinuation in patients with recovered heart function.
Extensive research in blood cancers, including multiple myeloma, acute myeloid leukemia, and various lymphomas. Studies evaluate novel drug combinations and treatment strategies.
Investigations include targeted therapies and personalized treatment approaches for various cancer types.
Research focusing on respiratory syncytial virus (RSV) prevention in infants and children. Studies evaluate new protective treatments and their safety profiles.
Trials include assessment of novel medications for preventing severe respiratory infections in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
